These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26831719)

  • 41. Immunohistochemical assessment of localization and frequency of micrometastases in lymph nodes of colorectal cancer.
    Noura S; Yamamoto H; Miyake Y; Kim Bn; Takayama O; Seshimo I; Ikenaga M; Ikeda M; Sekimoto M; Matsuura N; Monden M
    Clin Cancer Res; 2002 Mar; 8(3):759-67. PubMed ID: 11895906
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical significance of molecular detection of carcinoma cells in lymph nodes and peripheral blood by reverse transcription-polymerase chain reaction in patients with gastrointestinal or breast carcinomas.
    Mori M; Mimori K; Ueo H; Tsuji K; Shiraishi T; Barnard GF; Sugimachi K; Akiyoshi T
    J Clin Oncol; 1998 Jan; 16(1):128-32. PubMed ID: 9440733
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prospective study of the quantitative carcinoembryonic antigen and cytokeratin 20 mRNA detection in peritoneal washes to predict peritoneal recurrence in gastric carcinoma patients.
    Tamura N; Iinuma H; Takada T
    Oncol Rep; 2007 Mar; 17(3):667-72. PubMed ID: 17273749
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Postoperative serum CA19-9, YKL-40, CRP and IL-6 in combination with CEA as prognostic markers for recurrence and survival in colorectal cancer.
    Hermunen K; Soveri LM; Boisen MK; Mustonen HK; Dehlendorff C; Haglund CH; Johansen JS; Osterlund P
    Acta Oncol; 2020 Dec; 59(12):1416-1423. PubMed ID: 32790589
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Significance of carcinoembryonic antigen mRNA in peritoneal lavage determined by transcription-reverse transcription concerted method in patients with low rectal cancer.
    Murono K; Ishihara S; Kawai K; Kaneko M; Sasaki K; Otani K; Yasuda K; Nishikawa T; Tanaka T; Kiyomatsu T; Hata K; Nozawa H; Satoh Y; Kurihara M; Yatomi Y; Watanabe T
    Asian J Surg; 2018 Jul; 41(4):321-327. PubMed ID: 28291565
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lymph node tissue kallikrein-related peptidase 6 mRNA: a progression marker for colorectal cancer.
    Ohlsson L; Lindmark G; Israelsson A; Palmqvist R; Öberg Å; Hammarström ML; Hammarström S
    Br J Cancer; 2012 Jun; 107(1):150-7. PubMed ID: 22699826
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessment of Duration and Effects of 3 vs 6 Months of Adjuvant Chemotherapy in High-Risk Stage II Colorectal Cancer: A Subgroup Analysis of the TOSCA Randomized Clinical Trial.
    Petrelli F; Labianca R; Zaniboni A; Lonardi S; Galli F; Rulli E; Rosati G; Corallo S; Ronzoni M; Cardellino GG; Mattioli R; Mambrini A; Ciuffreda L; Banzi M; Pusceddu V; Maiello E; Zampino M; Zagonel V; Marchetti P; Corsi D; Rimassa L; Cinieri S; Sobrero A
    JAMA Oncol; 2020 Apr; 6(4):547-551. PubMed ID: 32053133
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Postoperative chemotherapy for colorectal cancer by combining 5-fluorouracil infusion and 1-hexylcarbamoyl-5-fluorouracil administration after curative resection.
    Sugimachi K; Maehara Y; Ogawa M; Kakegawa T; Tomita M; Akiyoshi T
    Cancer; 1996 Jan; 77(1):36-43. PubMed ID: 8630937
    [TBL] [Abstract][Full Text] [Related]  

  • 49. TBL1XR1 predicts isolated tumor cells and micrometastasis in patients with TNM stage I/II colorectal cancer.
    Liu H; Liu Z; Li K; Li S; Song L; Gong Z; Shi W; Yang H; Xu Y; Ning S; Ismail S; Chen Y
    J Gastroenterol Hepatol; 2017 Sep; 32(9):1570-1580. PubMed ID: 28127799
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detection of occult lymph node metastases in esophageal cancer by minimally invasive staging combined with molecular diagnostic techniques.
    Kassis ES; Nguyen N; Shriver SP; Siegfried JM; Schauer PR; Luketich JD
    JSLS; 1998; 2(4):331-6. PubMed ID: 10036123
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Prognostic Significance of Isolated Tumor Cells Detected Within Lateral Lymph Nodes in Rectal Cancer Patients After Laparoscopic Lateral Lymph Node Dissection.
    Yang X; Hu T; Gu C; Yang S; Jiang D; Deng X; Wang Z; Zhou Z
    J Laparoendosc Adv Surg Tech A; 2019 Nov; 29(11):1462-1468. PubMed ID: 31539301
    [No Abstract]   [Full Text] [Related]  

  • 52. Prognostic factors of patients with left-sided obstructive colorectal cancer: post hoc analysis of a retrospective multicenter study by the Japan Colonic Stent Safe Procedure Research Group.
    Endo S; Isohata N; Kojima K; Kadono Y; Amano K; Otsuka H; Fujimoto T; Egashira H; Saida Y;
    World J Surg Oncol; 2022 Jan; 20(1):24. PubMed ID: 35086523
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of half-life of carcinoembryonic antigen (CEA) in prognosis prediction of colorectal cancer patients with preoperatively elevated CEA.
    Yuan SQ; Zhou ZW; Wan DS; Chen G; Lu ZH; Wang GQ; Pan ZZ
    Ai Zheng; 2008 Jun; 27(6):612-7. PubMed ID: 18570735
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic information derived from RT-PCR analysis of peritoneal fluid in gastric cancer patients: results from a prospective multicenter clinical trial.
    Tamura S; Fujiwara Y; Kimura Y; Fujita J; Imamura H; Kinuta M; Yano M; Hiratsuka M; Kobayashi K; Okada K; Mori M; Doki Y
    J Surg Oncol; 2014 Feb; 109(2):75-80. PubMed ID: 24155213
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Central retroperitoneal recurrences from colorectal cancer: are lymph node and locoregional recurrences the same disease?
    Dumont F; Kothodinis K; Goéré D; Honoré C; Dartigues P; Boige V; Ducreux M; Malka D; Elias D
    Eur J Surg Oncol; 2012 Jul; 38(7):611-6. PubMed ID: 22525856
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Predictive value of combination detection of tissue Pgp1 expression and preoperative serum CEA level for colorectal cancer].
    Wu F; Chen L; Wu W; Jiang B; Su X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):443-449. PubMed ID: 28440527
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic value of radiologically enlarged lymph nodes in patients with metastatic colorectal cancer: Subgroup findings of the randomized, open-label FIRE-3/AIO KRK0306 trial.
    Hofmann FO; Holch JW; Heinemann V; Ricard I; Reiser MF; Baumann AB; Hesse N; D'Anastasi M; Modest DP; Stintzing S; Sommer WH
    Eur J Radiol; 2018 Mar; 100():124-129. PubMed ID: 29496069
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic significance of cytokeratin-20 reverse transcriptase polymerase chain reaction in lymph nodes of node-negative colorectal cancer patients.
    Rosenberg R; Hoos A; Mueller J; Baier P; Stricker D; Werner M; Nekarda H; Siewert JR
    J Clin Oncol; 2002 Feb; 20(4):1049-55. PubMed ID: 11844829
    [TBL] [Abstract][Full Text] [Related]  

  • 59. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
    Stanisavljević L; Myklebust MP; Leh S; Dahl O
    Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic value of lymphovascular invasion in stage II colorectal cancer patients with an inadequate examination of lymph nodes.
    Gao Z; Cao H; Xu X; Wang Q; Wu Y; Lu Q
    World J Surg Oncol; 2021 Apr; 19(1):125. PubMed ID: 33866973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.